SENJIQA
LIVE

Serial Number

79245716

Owner

NOVARTIS AG

Filing Date

Oct 5, 2018

Add to watchlist:

No watchlists yet
View on USPTO

SENJIQA Trademark

Serial Number: 79245716 • Registration: 5724472

SENJIQA is a trademark filed by NOVARTIS AG on October 5, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

October 5, 2018

Registration Date

April 16, 2019

Published for Opposition

January 29, 2019

Cancellation Date

December 15, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Jan 2, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jan 2, 2023 DETH
NOTIFICATION PROCESSED BY IB
Jun 7, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
May 22, 2019 FICS
FINAL DISPOSITION PROCESSED
May 22, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
May 16, 2019 GPAR
REGISTERED-PRINCIPAL REGISTER
Apr 16, 2019 R.PR
PUBLISHED FOR OPPOSITION
Jan 29, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Jan 25, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 9, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 9, 2019 OP2R
NOTICE OF PUBLICATION
Jan 9, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 20, 2018 CNSA
ASSIGNED TO EXAMINER
Dec 14, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 30, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 26, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 24, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 22, 2018 REPR